baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC BON.CAP.CERT. 03/25 MRK/ DE000HD4V6N4 /

1/23/2025 9:46:49 PM	Chg.+0.050	Bid9:59:19 PM	Ask9:59:19 PM	Underlying	Strike price	Expiration date	Option type
169.210EUR	+0.03%	169.060 Bid Size: 400	169.480 Ask Size: 400	MERCK KGAA O.N.	- -	3/28/2025	Call

TeleTrader 10/31/2024 Merck's Q3 sales up 4% to $16.7 billion

TeleTrader 7/30/2024 Merck falls 7% after Q2 earnings report

TeleTrader 7/30/2024 Merck's Q2 sales up 7% to $16.1 billion

GlobeNewswire 6/3/2024 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...

TeleTrader 5/29/2024 Merck to buy biotech firm EyeBio for up to $3B

GlobeNewswire 5/29/2024 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...

GlobeNewswire 5/29/2024 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study

GlobeNewswire 5/7/2024 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 5/6/2024 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 5/2/2024 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 4/25/2024 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 4/2/2024 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 3/4/2024 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 2/2/2024 Merck Group to expand investment in South Korea

TeleTrader 2/1/2024 Merck's Q4 sales up 6% to $14.6B

TeleTrader 1/27/2024 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 1/23/2024 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 12/14/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

TeleTrader 10/26/2023 Merck's Q3 sales up 7% to $16B

TeleTrader 10/20/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs

GlobeNewswire 10/17/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA

GlobeNewswire 9/28/2023 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration

TeleTrader 8/29/2023 US gov't reveals drugs subject to Medicare price debate

TeleTrader 8/1/2023 Merck posts Q2 sales of $15B, rising 3%

UC BON.CAP.CERT. 03/25 MRK/ DE000HD4V6N4 /

If you wish to receive reply to your feedback, please provide your email address.